Pulmatrix to host KOL webinar on PUR3100 for acute migraine on Feb 3, 2023

Pulmatrix, Inc.

Webinar on Feb 3, 2023 at 10:00 AM ET, featuring Prof. Stewart Tepper (Dartmouth).
Dr. Margaret Wasilewski to provide update on Phase 1 data for inhaled DHE candidate PUR3100.
Event aims to discuss migraine treatment landscape, DHE mechanism, and future clinical plans.

item 7.01 item 9.01

Pulmatrix, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-002394

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.